Women in Pharma – Sukhada Chaturvedi Pharmapack 2023
This year at Pharmapack 2023, we interviewed several leading women in the pharmaceutical industry about what it means to be a woman working in pharma. In the lead-up to International Women’s Day on March 8, 2023, CPHI Online is proud to highlight the women taking strides to make the industry a more inclusive and diverse workforce, and by extension an equal opportunity healthcare landscape.
We caught up with Sukhada Chaturvedi, International Account Manager at Körber, to discuss her journey through the pharmaceutical industry as a woman in STEM, and the challenges as well as strategies for creating an equal healthcare landscape.
Innovation requires diversity of gender and beyond
The female workforce, as Chaturvedi stated, faces more challenges than the male workforce in the pharmaceutical industry. Speaking from experience, Chaturvedi described having less opportunities available for women in the pharmaceutical workforce, especially in terms of divisions such as mechanics or sales. Female representation within the pharma industry should start at recruitment and the implementation of training to achieve and increase diversity within the team, she claimed.
Chaturvedi also extended the idea of diversity to other aspects of the human experience. Diversity of age, race, and background along with diversity of gender will naturally lead to a diversity of opinion – a necessary component for the pharmaceutical industry to innovate and push the future of healthcare forward. With women constituting 50% of the human population, Chaturvedi described how women bring forth 50% of new ideas and opinions to the pharmaceutical industry. “We bring more innovation, our experiences, our empath... Everything that we do in pharma is for the patients. The empathy part comes very naturally to women and I believe [bringing] that perspective would contribute a lot of changes in pharma,” Chaturvedi explained.
The future of pharma is female
“This should actually not be a topic of discussion because diversity should be the norm,” Chaturvedi proclaimed, but she remained aware that the pharmaceutical industry is still taking ‘baby steps’ to achieving true diversity and equality.
For women looking to start a career in pharmaceuticals or even for women currently working in one of the many pharmaceutical sectors, Chaturvedi encouraged all to set their sights on their goals: “I believe there is no stopping for women of any colour. Just take your passion with you, take everything else with a pinch of salt, and go for your goal.” She emphasised the importance of working together and in solidarity to strive towards individual goals – no one woman can do it alone.
She also encouraged everyone in the pharmaceutical industry, men and women of any department and position, to continue these discussions regarding gender equality. From female CEOs and managing directors to contractors to manufacturers, Chaturvedi believes that the pharma industry is still taking baby steps towards the big leap, part of which will be continuing the discussion: “I believe in the future, we will have [total gender equality] as a norm.”
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News Sanofi to collaborate with OpenAI and Formation Bio
Pharmaceutical giant Sanofi have announced a collaboration with Formation Bio and OpenAI to build AI-powered software for accelerated drug development. -
News AstraZeneca to build billion-dollar ADC manufacturing site in Singapore
The British-Swedish drugmaker has announced plans to build a US$1.5 billion facility in Singapore for the manufacturing of antibody–drug conjugates (ADCs) to complement their existing cancer drug portfolio. -
News Women in Pharma: Delivering personal and professional success
In our monthly series focusing on women in the pharmaceutical industry, we interview leading experts in the pharmaceutical supply and value chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Eisai begins US FDA rolling submission for Alzheimer’s drug Leqembi
Japanese drugmaker Eisai, in partnership with Biogen, have announced that they have begun submitting data on a rolling basis to the US FDA for a marketing application of a subcutaneous injectable form of Alzheimer’s drug Leqembi. -
News Racial disparities in diagnosis and drug use for dementia symptoms
A study from the USC Schaeffer Center for Health Policy & Economics has revealed the existence of racial disparities in the US for the diagnosis of dementia and the use of drug treatments for symptoms. -
News MDMA-assisted therapy for PTSD to be reviewed by US FDA
American public benefit corporation (PBC) Lykos Therapeutics have announced that the US FDA Psychopharmacologic Drugs Advisory Committee (PDAC) will review data supporting their new drug application (NDA) for MDMA capsules, which are to be used in comb... -
News Drug Patent Expiries: a steep cliff or opportunity for innovation?
The pharmaceutical industry faces a patent cliff together in the years leading up to 2030. Learn what this means for drug pricing, their outsourcing partners, and drug innovation of the future.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance